From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

Vertex has entered a reimbursement agreement with NHS England enabling eligible SCD patients to access Casgevy in the public ...

If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...

I am writing to express my strong opposition to the proposed installation of a 120-foot cell tower on the grounds of St. Elizabeth Ann Seton Church in North Falmouth, which ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

Gemini 2.0 Flash is the base model that powers the free version of Gemini. It replaces Gemini 1.5 Flash which was released ...

Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

Creating handmade flower planters involves skillful craftsmanship and precise techniques. Each stage, from molding raw ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associated with opioids. The drug, which works by ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...